CANCER GENETICS, INC | 2013 | FY | 3


On April 10, 2013, we completed our IPO and converted the following indebtedness into shares of common stock at the IPO price of $10.00 per share:

 

     Converted Amount      Common Shares  

December 2011 Financing Transaction

   $ 4,500,000         450,000   

2012 Convertible Debt Financing Transaction

     3,000,000         300,000   

December 2012 Bridge Financing Transaction

     1,000,000         100,000   

Business Lines of Credit (DAM)

     1,000,000         100,000   

Other Note Payable and accrued interest

     134,300         13,430   
  

 

 

    

 

 

 
   $ 9,634,300         963,430   
  

 

 

    

 

 

 

us-gaap:ScheduleOfDebtConversionsTextBlock